Dr. Keith Pardee

Synthetic biology and bioengineering have the potential to meet a lot of global challenges. For instance, recent advances in cell-free synthetic biology have enabled my team to develop SARS-CoV-2 diagnostics, leveraging widely available point-of-care sensing devices such as glucose meters, to serve as nucleic acid sensors for variants of concern detection; for which international technology transfer efforts are now underway with researchers in Latin America and Asia.